GAA
Green Alpha Advisors Portfolio holdings
AUM
$105M
This Quarter Return
+5.76%
1 Year Return
+34.49%
3 Year Return
+117.38%
5 Year Return
–
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(-9.9%)
Cap. Flow
-$13.9M
Cap. Flow
% of AUM
-11.2%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
143
New
1
Increased
3
Reduced
134
Closed
5
Top Buys
| 1 |
Guardant Health
GH
|
$205K |
| 2 |
Nextracker
NXT
|
$95.2K |
| 3 |
AXS Green Alpha ETF
NXTE
|
$1.28K |
Top Sells
| 1 |
TSMC
TSM
|
$640K |
| 2 |
Lam Research
LRCX
|
$617K |
| 3 |
Applied Materials
AMAT
|
$458K |
| 4 |
Qualcomm
QCOM
|
$445K |
| 5 |
IBM
IBM
|
$427K |
Sector Composition
| 1 | Technology | 48.01% |
| 2 | Real Estate | 16.13% |
| 3 | Healthcare | 6.95% |
| 4 | Consumer Staples | 6.8% |
| 5 | Consumer Discretionary | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Quantum-Si Incorporated
QSI
$217M
| $136K | 0.11% |
129,259
-5,357
| -4% | -$5.63K |
|
127
Prime Medicine
PRME
$595M
| $135K | 0.11% |
26,245
-7,493
| -22% | -$38.5K |
|
128
Butterfly Network
BFLY
$378M
| $135K | 0.11% |
160,200
-6,844
| -4% | -$5.75K |
|
129
Personalis
PSNL
$430M
| $127K | 0.1% |
108,591
-10,362
| -9% | -$12.1K |
|
130
Caribou Biosciences
CRBU
$176M
| $127K | 0.1% |
77,371
-6,150
| -7% | -$10.1K |
|
131
Gogoro
GGR
$106M
| $111K | 0.09% |
72,179
-3,986
| -5% | -$6.14K |
|
|
VERV
132
DELISTED
Verve Therapeutics
VERV
| $94.8K | 0.08% |
19,433
-5,507
| -22% | -$26.9K |
|
133
Energy Vault
NRGV
$348M
| $92.5K | 0.07% |
97,446
-4,461
| -4% | -$4.24K |
|
134
Ginkgo Bioworks
DNA
$671M
| $74.4K | 0.06% |
5,567
-1,874
| -25% | -$25.1K |
|
135
AbCellera Biologics
ABCL
$1.19B
| $73.1K | 0.06% |
24,709
-3,638
| -13% | -$10.8K |
|
136
CureVac
CVAC
$1.21B
| $65.8K | 0.05% |
19,340
-2,778
| -13% | -$9.45K |
|
137
Pacific Biosciences
PACB
$378M
| $46.7K | 0.04% |
34,096
-15,851
| -32% | -$21.7K |
|
138
Maxeon Solar Technologies
MAXN
$62.1M
| $38.2K | 0.03% |
447
-14
| -3% | -$1.2K |
|
139
Arcturus Therapeutics
ARCT
$467M
| – | – |
-8,414
| Closed | -$284K |
|
140
Exact Sciences
EXAS
$9.33B
| – | – |
-4,469
| Closed | -$309K |
|
141
Intellia Therapeutics
NTLA
$1.26B
| – | – |
-7,964
| Closed | -$219K |
|
142
10x Genomics
TXG
$1.66B
| – | – |
-5,713
| Closed | -$214K |
|
|
NVTA
143
DELISTED
Invitae Corporation
NVTA
| – | – |
-450,148
| Closed | -$4.95K |
|